Niemann-Pick Disease Type C Treatment; a Medication Called Miglustat (Zavesca) May Be an Option
No effective Niemann-Pick disease type C treatment is
available for people with type A or B, but for people with mild to moderate
type C, a medication called miglustat (Zavesca) may be an option. However, there
is no cure for Niemann-Pick disease. Children usually die from infection or
progressive neurological loss. Niemann-Pick is a rare, inherited disease that
affects the body's ability to metabolize fat (lipids and cholesterol) within
cells. Niemann-Pick disease can affect the bone marrow, spleen, liver, nerves,
brain, and, in severe cases, lungs. Niemann-Pick type C is a lysosomal storage
disease associated with mutations in NPC1 and NPC2 genes.
Niemann-Pick type C (NPC) is a slowly progressive disorder
whose principal manifestations are age dependent. In infants, Niemann-Pick
disease type C leads to various disorders such as Gaucher disease, idiopathic
neonatal cholestasis, alpha-1-antitrypsin deficiency, tyrosinemia, and various
congenital infections. According to the National Organization for Rare
Disorders 2020 report, the frequency of NPC is similar in both men and women,
wherein it is estimated to occur in 1 in 100,000-120,000 live births. It is
also known as Childhood Alzheimer's, and as with Alzheimer's disease, there is
no current Niemann-Pick
disease type C treatment available.
However, there are some promising new treatments being
tested in clinical trials for the symptoms of this condition. For instance, in
February 2020, Cyclo Therapeutics announced the completion of enrollment in its
phase 1/2 trial to evaluate the tolerability, safety, and efficacy of Trappsol
Cyclo for Niemann pick disease type C treatment. Niemann-Pick disease is
divided into four main types, such as type A, B, C1, and C2. These types are
classified on the basis of genetic cause and the signs and symptoms of the
condition. Type C1 is the most common form of the disease and type C2 is a rare
form of the disease. However, there is currently no cure for Niemann-Pick
disease.
Comments
Post a Comment